Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination
- PMID: 35271696
- PMCID: PMC8916825
- DOI: 10.1182/blood.2021015149
Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination
References
-
- Joly BS, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura. Blood. 2017;129(21):2836-2846. - PubMed
-
- Mariotte E, Azoulay E, Galicier L, et al. ; French Reference Center for Thrombotic Microangiopathies . Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy. Lancet Haematol. 2016;3(5):e237-e245. - PubMed
MeSH terms
Substances
LinkOut - more resources
Medical